XXXXX AND COMPANY Sample Clauses

XXXXX AND COMPANY. By: /s/ X. Xxxxxxx Xxxxxxxxx Name: X. Xxxxxxx Xxxxxxxxx Title: V.P. – General Counsel and Secretary
AutoNDA by SimpleDocs
XXXXX AND COMPANY. By: /s/ Xxxxxx X. Xxxxxx Xxxxxx X. Xxxxxx President and Chief Executive Officer
XXXXX AND COMPANY. Lilly is a global healthcare leader that unites caring with discovery to make life better for people around the world. We were founded more than a century ago by a man committed to creating high-quality medicines that meet real needs, and today we remain true to that mission in all our work. Across the globe, Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism. To learn more about Lilly, please visit us at xxx.Xxxxx.xx.xx This press release contains forward-looking statements about the potential benefits of the research collaboration between Lilly and Immunocore and reflects Lilly’s current beliefs. However, there are substantial risks and uncertainties in the process of drug research, development, and commercialization. There is no guarantee that the research collaboration will yield successful results or that either company will achieve the anticipated benefits. For further discussion of these and other risks and uncertainties, see Lilly’s filings with the United States Securities and Exchange Commission. Lilly undertakes no duty to update forward-looking statements. # # # Exhibit E to Development and License Agreement CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [***], HAS BEEN OMITTED BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) IS THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL. Xxx Xxxxx and Company Lilly Xxxxxxxxx Xxxxxx Xxxxxxxxxxxx, Xxxxxxx 00000 X.X.X. xxx.Xxxxx.xx.xx Immunocore Ltd. 00 Xxxxxx Xxxx Abingdon, Oxfordshire OX14 4RY U.K. xxx.xxxxxxxxxx.xxx Date: July XX, 2014 For Release: Draft Refer to: [***] LILLY AND IMMUNOCORE ENTER IMMUNOTHERAPY AGREEMENT TO CO-DISCOVER AND CO-DEVELOP NOVEL CANCER THERAPIES (Oxford, UK and Indianapolis, IN) Xxx Xxxxx and Company (NYSE: LLY) and Immunocore Limited today announced they have entered into a co-discovery and co-development collaboration to research and potentially develop novel T cell-based cancer therapies. Using Immunocore’s Immune Mobilising Monoclonal T-Cell Receptor Against Cancer (ImmTAC) technology, the companies will seek to use the power of the body’s own immune system to attack cancer cells. ImmTACs have shown potential to direct a patient’s T cells to specifically target the cancerous cells, avoiding damage to healthy cells. Under the terms of the agreement, Immunocore will receive an upfront ...
XXXXX AND COMPANY. Lilly is a global healthcare leader that unites caring with discovery to make life better for people around the world. We were founded more than a century ago by a man committed to creating high-quality medicines that meet real needs, and today we remain true to that mission in all our work. Across the globe, Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism. To learn more about Lilly, please visit us at xxx.xxxxx.xxx and xxxx://xxxxxxxx.xxxxx.xxx/social-channels
XXXXX AND COMPANY. By: /s/ Xxx Xxxxxxx Name: Xxx Xxxxxxx Title: Authorized Person X. XXXXX ASSOCIATES, INC. By: /s/ Xxx Xxxxxxx Name: Xxx Xxxxxxx Title: Authorized Person THE XXXXX GROUP, LLC By: /s/ Xxx Xxxxxxx Name: Xxx Xxxxxxx Title: Authorized Person Annex A Founder Shares* Private Placement Warrants Xxxxxxxxx Sponsor III LLC 27,500,000 (of which 12,404,080 are Vesting Shares) 23,000,000, which may be increased to up to 24,500,000 in accordance with paragraph 8 above and Section 6.11 of the Merger Agreement (in each case, of which 4,800,000 are Vesting Warrants and Locked- Up Warrants) Xxxxxxx Xxxxx 0** 0** Xxx Xxxxxxx 0 0 * Includes shares of Common Stock issued or issuable upon the exercise or conversion of the Founder Shares. ** Xxxxxxx Xxxxx may be deemed to Beneficially Own the Founders Shares and Private Placement Warrants owned by Xxxxxxxxx Sponsor III LLC.
XXXXX AND COMPANY. By: /s/ Xxxxxx X. Xxxxxx Name: Xxxxxx X. Xxxxxx Title: President/CEO
XXXXX AND COMPANY. Any amounts so deferred shall accrue until the Company's receipt of such funds.
AutoNDA by SimpleDocs

Related to XXXXX AND COMPANY

  • Xxxxxx and Recall An employee in receipt of notice of layoff pursuant to 9.08(A)(a)(ii) may:

  • Xxxx and Xx Xxxxxxxx: Pursuant to Section 1(i) of the Investment Management Trust Agreement between Climate Real Impact Solutions II Acquisition Corporation (the “Company”) and Continental Stock Transfer & Trust Company (the “Trustee”), dated as of _________, 2021 (the “Trust Agreement”), this is to advise you that the Company did not effect a business combination with a Target Business (the “Business Combination”) within the time frame specified in the Company’s amended and restated certificate of incorporation, as described in the Company’s Prospectus relating to the Offering. Capitalized terms used but not defined herein shall have the meanings set forth in the Trust Agreement. In accordance with the terms of the Trust Agreement, we hereby authorize you to liquidate all of the assets in the Trust Account and transfer the total proceeds into a segregated account held by you on behalf of the Beneficiaries to await distribution to the Public Stockholders. The Company has selected [_________, 20__]1 as the effective date for the purpose of determining when the Public Stockholders will be entitled to receive their share of the liquidation proceeds. You agree to be the Paying Agent of record and, in your separate capacity as Paying Agent, agree to distribute said funds directly to the Company’s Public Stockholders in accordance with the terms of the Trust Agreement and the Company’s amended and restated certificate of incorporation. Upon the distribution of all the funds, net of any payments necessary for reasonable unreimbursed expenses related to liquidating the Trust Account, your obligations under the Trust Agreement shall be terminated, except to the extent otherwise provided in Section 1(i) of the Trust Agreement. Very truly yours, Climate Real Impact Solutions II Acquisition Corporation By: Name: Title: cc: Barclays Capital Inc. BofA Securities, Inc.

  • Xxxxxxx and X Xxxx¨cker. A detailed account of Xxxxx Xxxxxx’ version of the standard model. IV. Rev. Math. Phys. 8 (1996) 205–228.

  • Xxxxxxxx and X Xxxxx. Generalized FLP impossibility result for t-resilient asynchronous computations. STOC 1993: Proceedings of the twenty-fifth annual ACM symposium on Theory of computing, pp. 91–100. ACM, New York (1993)

  • XXXXXXXX AND W XXXXXXX XXXXXX

  • Xxxxxxxxx and X Xxxxxxx. A

  • Xxxxxx and X Xxx, “A unified monotonic approach to generalized linear fractional programming,” Journal of Global Optimization, vol. 26, no. 3, pp. 229–259, 2003. [14] X. X. Xxxx, X. X. Xxxxx, and X. Xxxxx, “Xxxxx: Achieving global optimality for a non-convex wireless power control problem,” IEEE Transactions on Wireless Communications, vol. 8, no. 3, pp. 1553–1563, Mar 2009. [15] X. Xxxxxxxx and X. Xxxxxxx, “Common randomness in information theory and cryptography - part I: Secret sharing,” IEEE Transactions on Information Theory, vol. 39, no. 4, pp. 1121–1132, Jul. 1993. [16] I. Safaka, X. X. Xxxxxxxxxx, X. Xxxxxxx, E. Atsan, C. Fragouli, X. Xxxxxxxx, and X. Xxxxxxx, “Exchanging Secrets without Using Cryptography,” arXiv:1105.4991 [cs, math], May 2011, arXiv: 1105.4991. [Online]. Available: xxxx://xxxxx.xxx/abs/1105.4991 [17] I. Safaka, C. Fragouli, X. Xxxxxxxx, and X. Xxxxxxx, “Exchanging pairwise secrets efficiently,” in 2013 Proceedings IEEE INFOCOM, Apr. 2013, pp. 2265–2273.‌ [18] E. Atsan, I. Safaka, X. Xxxxxx, and X. Xxxxxxxx, “Low cost security for sensor networks,” in 2013 International Symposium on Network Coding (NetCod), Jun. 2013, pp. 1–6. [19] X. Xxxxxxxx, X. Xxxxxxx, X. Xxxxxx, X. Xxxxxxxx, X. Xxxxxxxxx, and X. Xxxxxxxxxxx, “Creating Secrets out of Erasures,” in Proceedings of the 19th Annual International Conference on Mobile Computing & Networking, ser. MobiCom ’13. New York, NY, USA: ACM, 2013, pp. 429–440. [Online]. Available: xxxx://xxx.xxx.xxx/10.1145/2500423.2500440 [20] X. X. Xxxx and X. Xxxxxxxxxxxx, Convex Optimization. Cambridge University Press, Mar. 2004. [21] X. X. Xxxxxxxxx, X. Xxxxx, and X. X. Xxxxxxxx, Convex Analysis and Optimization. Athena Scientific, 2003. [22] X. Xxxx, X. X. Xxxxxxxxxxx, X. Xxxxxxxx, and X. X. Xxxxxxx, “Secret communication over broadcast erasure channels with state-feedbac,” IEEE Transactions on Information Theory, vol. 61, pp. 4788–4808, Sep. 2015. [23] X. X. XxxXxxxxxxx, The Theory of Error-Correcting Codes, 2nd ed. Amsterdam; New York; New York: North Holland Publishing Co., 1978. [24] C. Fragouli and X. Xxxxxxxx, Network Coding Fundamentals. Hanover, MA: Now Publishers Inc, Jun. 2007.

  • xxx/OpenGovernment/LobbingAtOrangeCounty aspx A lobbying blackout period shall commence upon issuance of the solicitation until the Board selects the Contractor. For procurements that do not require Board approval, the blackout period commences upon solicitation issuance and concludes upon contract award. The County may void any contract where the County Mayor, one or more County Commissioners, or a County staff person has been lobbied in violation of the black-out period restrictions of Ordinance No. 2002-15. • Orange County Protest Procedures xxxx://xxx.xxxxxxxxxxxxxx.xxx/VendorServices/XxxxxxXxxxxxxXxxxxxxxxx.xx px Failure to file a protest with the Manager, Procurement Division by 5:00 PM on the fifth full business day after posting, shall constitute a waiver of bid protest proceedings.

  • Xxxxxxxx Tobacco Co the jury returned a verdict in favor of the plaintiff, found the decedent, Xxxxxxx Xxxxxx, to be 30% at fault and RJR Tobacco to be 70% at fault, and awarded $7 million in compensatory damages and $8.5 million in punitive damages.

  • Destination CSU-Pueblo scholarship This articulation transfer agreement replaces all previous agreements between CCA and CSU-Pueblo in Bachelor of Science in Physics (Secondary Education Emphasis). This agreement will be reviewed annually and revised (if necessary) as mutually agreed.

Time is Money Join Law Insider Premium to draft better contracts faster.